Vaccines dramatically reduces COVID-19 risk, experts say, though infections still possible
Updated Apr 03, 2021;
Posted Apr 03, 2021
Pfizer-BioNTech COVID-19 doses are prepared at a vaccine outreach clinic at Mt. Zion Baptist Church in Kalamazoo, Michigan on Tuesday, March 23, 2021. The clinic was put on by the Kalamazoo County Health Department with volunteers from Mt. Zion. (Joel Bissell | MLive.com)
Facebook Share
Yes, the COVID-19 vaccine works.
After two weeks, one vaccine shot is 80% effective at preventing infections, while a second shot carries 90% effectiveness, according to a new CDC study.
“Our data from the CDC today suggest that vaccinated people do not carry the virus,” said CDC Director Dr. Rochelle Walensky in an MSNBC interview from Tuesday, March 30.
Michigan’s COVID-19 surge is the worst in the nation. Whitmer is focused on vaccines, not restrictions.
Updated 8:34 AM;
Today 8:34 AM
Michigan Governor Gretchen Whitmer talks with Detroit Lions Team President and CEO Rod Wood as they walk off the stage after a press conference announcing a mass COVID-19 vaccination clinic at Ford Field in Detroit, on Thursday, March 18, 2021. (Mike Mulholland | MLive.com)
Facebook Share
Last week at an event hosted by the Michigan Chronicle, Gov. Gretchen Whitmer did a rare in-person interview. She had been doing most of them remotely due to the risk of COVID-19, and the risk wasn’t any lower that day, as she sat in the studio unmasked.
Study: Race made no difference in ICU Outcomes of COVID-19 patients eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
E-Mail
IMAGE: Eleanor M. Walker, M.D., PAACT co-investigator, and director of Breast Radiation Oncology and medical director of Integrative Services at Henry Ford view more
Credit: Henry Ford Health System
DETROIT (March 11, 2021) - Henry Ford Cancer Institute is launching the Participatory Action for Access to Clinical Trials (PAACT) project to dramatically improve the representation of the African American community and other minorities in cancer clinical trials.
Supported by a $750,000 grant from Genentech, PAACT is a community-based research initiative in collaboration with the Detroit Community-Academic Urban Research Center (Detroit URC) that will address various barriers to trust and participation in clinical trials. Researchers and community partners will focus on clinical trials involving breast, colorectal, lung, and prostate cancers, which are more likely to result in death for African Americans when compared to other racial and ethnic groups. The project
E-Mail
IMAGE: L. Keoki Williams, M.D., MPH, the study s senior author and co-Director of Henry Ford Health System s Center for Individualized and Genomic Medicine Research. view more
Credit: Henry Ford Health System
DETROIT (February 25, 2021) - Researchers at Henry Ford Health System, as part of a national asthma collaborative, have identified a gene variant associated with childhood asthma that underscores the importance of including diverse patient populations in research studies.
The study is published in the print version of the
American Journal of Respiratory and Critical Care Medicine.
For 14 years researchers have known that a casual variant for early onset asthma resides on chromosome 17, which holds one of the most highly replicated and significant genetic associations with asthma. Henry Ford researchers acknowledged they would not have identified it in this study without a diverse patient population that included African Americans, many from the metro D